161 related articles for article (PubMed ID: 34117747)
21. Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10.
Huijts PE; van Dongen M; de Goeij MC; van Moolenbroek AJ; Blanken F; Vreeswijk MP; de Kruijf EM; Mesker WE; van Zwet EW; Tollenaar RA; Smit VT; van Asperen CJ; Devilee P
Breast Cancer Res; 2011 Jul; 13(4):R72. PubMed ID: 21767389
[TBL] [Abstract][Full Text] [Related]
22. CD146 attenuation in cancer-associated fibroblasts promotes pancreatic cancer progression.
Zheng B; Ohuchida K; Chijiiwa Y; Zhao M; Mizuuchi Y; Cui L; Horioka K; Ohtsuka T; Mizumoto K; Oda Y; Hashizume M; Nakamura M; Tanaka M
Mol Carcinog; 2016 Nov; 55(11):1560-1572. PubMed ID: 26373617
[TBL] [Abstract][Full Text] [Related]
23. MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2.
Sun Y; Zhang T; Wang C; Jin X; Jia C; Yu S; Chen J
PLoS One; 2015; 10(4):e0119783. PubMed ID: 25856297
[TBL] [Abstract][Full Text] [Related]
24. Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions.
Jiang Z; Zhou C; Cheng L; Yan B; Chen K; Chen X; Zong L; Lei J; Duan W; Xu Q; Li X; Wang Z; Ma Q; Ma J
J Exp Clin Cancer Res; 2018 Mar; 37(1):69. PubMed ID: 29587800
[TBL] [Abstract][Full Text] [Related]
25. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
[TBL] [Abstract][Full Text] [Related]
26. FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells.
Turczyk L; Kitowska K; Mieszkowska M; Mieczkowski K; Czaplinska D; Piasecka D; Kordek R; Skladanowski AC; Potemski P; Romanska HM; Sadej R
Neoplasia; 2017 Oct; 19(10):791-804. PubMed ID: 28869838
[TBL] [Abstract][Full Text] [Related]
27. Loss of MTSS1 results in increased metastatic potential in pancreatic cancer.
Zeleniak AE; Huang W; Brinkman MK; Fishel ML; Hill R
Oncotarget; 2017 Mar; 8(10):16473-16487. PubMed ID: 28146435
[TBL] [Abstract][Full Text] [Related]
28. A novel nuclear Src and p300 signaling axis controls migratory and invasive behavior in pancreatic cancer.
Paladino D; Yue P; Furuya H; Acoba J; Rosser CJ; Turkson J
Oncotarget; 2016 Feb; 7(6):7253-67. PubMed ID: 26695438
[TBL] [Abstract][Full Text] [Related]
29. Cancer-associated fibroblasts drive early pancreatic cancer cell invasion via the SOX4/MMP11 signalling axis.
Ge F; Zeng C; Wang J; Liu X; Zheng C; Zhang H; Yang L; Yang B; Zhu H; He Q
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166852. PubMed ID: 37633471
[TBL] [Abstract][Full Text] [Related]
30. Nectin-1 expression in cancer-associated fibroblasts is a predictor of poor prognosis for pancreatic ductal adenocarcinoma.
Yamada M; Hirabayashi K; Kawanishi A; Hadano A; Takanashi Y; Izumi H; Kawaguchi Y; Mine T; Nakamura N; Nakagohri T
Surg Today; 2018 May; 48(5):510-516. PubMed ID: 29256146
[TBL] [Abstract][Full Text] [Related]
31. CCDC88A, a prognostic factor for human pancreatic cancers, promotes the motility and invasiveness of pancreatic cancer cells.
Tanouchi A; Taniuchi K; Furihata M; Naganuma S; Dabanaka K; Kimura M; Watanabe R; Kohsaki T; Shimizu T; Saito M; Hanazaki K; Saibara T
J Exp Clin Cancer Res; 2016 Dec; 35(1):190. PubMed ID: 27919290
[TBL] [Abstract][Full Text] [Related]
32. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
[TBL] [Abstract][Full Text] [Related]
33. Arachidonate 12-lipoxygenase and 12-hydroxyeicosatetraenoic acid contribute to stromal aging-induced progression of pancreatic cancer.
Sarsour EH; Son JM; Kalen AL; Xiao W; Du J; Alexander MS; O'Leary BR; Cullen JJ; Goswami PC
J Biol Chem; 2020 May; 295(20):6946-6957. PubMed ID: 32265301
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma.
Kawase T; Yasui Y; Nishina S; Hara Y; Yanatori I; Tomiyama Y; Nakashima Y; Yoshida K; Kishi F; Nakamura M; Hino K
BMC Gastroenterol; 2015 Sep; 15():109. PubMed ID: 26330349
[TBL] [Abstract][Full Text] [Related]
35. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models.
Shinkai K; Nakano K; Cui L; Mizuuchi Y; Onishi H; Oda Y; Obika S; Tanaka M; Katano M
Int J Cancer; 2016 Jul; 139(2):433-45. PubMed ID: 26939718
[TBL] [Abstract][Full Text] [Related]
36. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
[TBL] [Abstract][Full Text] [Related]
37. FGF22 and its close relatives are presynaptic organizing molecules in the mammalian brain.
Umemori H; Linhoff MW; Ornitz DM; Sanes JR
Cell; 2004 Jul; 118(2):257-70. PubMed ID: 15260994
[TBL] [Abstract][Full Text] [Related]
38. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
[TBL] [Abstract][Full Text] [Related]
39. The NOTCH ligand JAGGED2 promotes pancreatic cancer metastasis independent of NOTCH signaling activation.
Hu Y; Su H; Li X; Guo G; Cheng L; Qin R; Qing G; Liu H
Mol Cancer Ther; 2015 Jan; 14(1):289-97. PubMed ID: 25351917
[TBL] [Abstract][Full Text] [Related]
40. DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA.
He X; Zheng Z; Li J; Ben Q; Liu J; Zhang J; Ji J; Yu B; Chen X; Su L; Zhou L; Liu B; Yuan Y
Carcinogenesis; 2012 Mar; 33(3):555-62. PubMed ID: 22223849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
